Akero Therapeutics Inc (AKRO)
28.89
+0.33
(+1.16%)
USD |
NASDAQ |
Dec 26, 16:00
28.90
+0.01
(+0.03%)
After-Hours: 20:00
Akero Therapeutics Cash from Investing (Quarterly): 73.07M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | -202.39M |
89bio Inc | -8.639M |
NovaBay Pharmaceuticals Inc | -0.002M |
Palatin Technologies Inc | 0.00 |
iBio Inc | 0.713M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -70.42M |
Cash from Financing (Quarterly) | 3.067M |
Free Cash Flow | -212.64M |
Free Cash Flow Per Share (Quarterly) | -1.014 |
Free Cash Flow Yield | -11.61% |